New Allston lab will train high schoolers to work in biomanufacturing
A nonprofit that's helping train the future drug manufacturing workforce is opening its new space at the mixed-use Allston Labworks campus.
Benzinga.com17d
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...
BioPharma Dive17d
Sanofi, Teva add to case for new bowel disease drug
Detailed trial results could help Sanofi and Teva Pharmaceuticals make a case that a drug they’ve been developing will be competitive with rival treatments from Merck & Co. and Roche. The data, ...
BioPharma Dive22d
Sanofi reaches consumer health deal; Supernus antidepressant fails study
Today, a brief rundown of news involving Sanofi and Supernus Pharmaceuticals, as well as updates from Arcus Biosciences, Gilead Sciences and Ultragenyx Pharmaceutical that you might have missed. Over ...
TechCrunch22d
Thinking Machines Lab is ex-OpenAI CTO Mira Murati’s new startup
Unsurprisingly, it’s focused on AI. Called Thinking Machines Lab, the startup, which came out of stealth today, intends to build tooling to “make AI work for [people’s] unique needs and ...
Wired22d
Mira Murati Is Ready to Tell the World What She’s Working On
Today she announced that indeed she is the CEO of a new public benefit corporation called Thinking Machines Lab. Its mission is to develop top-notch AI with an eye toward making it useful and ...
Benzinga.com23d
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Also Read: Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study As a rapid-acting insulin, Merilog helps lower mealtime blood sugar spikes and improve blood ...
Business Insider23d
Regeneron, Sanofi announce Dupixent sBLA accepted for priority review by FDA
Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the supplemental biologics license application for Dupixent to treat adults with bullous pemphigoid.
Space.com23d
Rocket Lab launches sharp-eyed Earth-observation satellite to orbit (video)
The "Fasten Your Space Belts' mission lifted off at 6:17 p.m. ET today (Feb. 18). Rocket Lab launched a high-resolution Earth-imaging satellite toward low Earth orbit this evening (Feb. 18).
Pharmabiz24d
US FDA approves Sanofi-Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes
Approval of biosimilar products can increase patient access to safe and effective treatment options. The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three ...
The University of Chicago Chronicle24d
Light Lab: Understanding the gut microbiome to treat disease
Editor’s Note: This is part of a series called Inside the Lab, which gives audiences a first-hand look at the research laboratories at the University of Chicago and the scholars who are tackling some ...
Business Insider26d
FDA approves Sanofi biosimilar product for treatment of diabetes
The FDA granted approval of Merilog to Sanofi (SNY)-Aventis U.S. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top ...